Drug Type Chemical drugs |
Synonyms |
Target |
Action inhibitors |
Mechanism ALKBH3 inhibitors(alkB homolog 3, alpha-ketoglutarate dependent dioxygenase inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | Japan | 11 May 2024 |